![LENSAR, Inc. logo](/logos/LNSR.webp)
LENSAR, Inc.
NASDAQ:LNSR
Overview | Financials
Company Name | LENSAR, Inc. |
Symbol | LNSR |
Currency | USD |
Price | 4.53 |
Market Cap | 52,586,052 |
Dividend Yield | 0% |
52-week-range | 1.8 - 5.6 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Nicholas T. Curtis |
Website | https://www.lensar.com |
An error occurred while fetching data.
About LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD